An EPFL start-up from the Laboratory of Systems Biology and Genetics, Alithea Genomics is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs.

Alithea Genomics secures CHF 500,000 to boost RNA sequencing technology

Monday 27 March 2023
The listing comes after the successful closing of the business combination between European Biotech Acquisition Corp. (EBAC) and Oculis SA.

Oculis lists on Nasdaq with strong clinical-stage pipeline in ophthalmology

Tuesday 7 March 2023
Izar is a unique smart peripheral device that has been FDA-listed and CE-marked to aid patients with hand motor dysfunction.

Mindmaze launches revolutionary device to improve hand recovery after stroke

Wednesday 1 March 2023
The new funds will be used to support the commercialization of Terapet's first product, Qualγscan, and the development of new nuclear imaging products.

Terapet raises CHF 2.3 million for its next-generation cancer treatment technology

Monday 27 February 2023
Limula's technology allows for the automated production of CAR-T therapies and other customized cell-based treatments.

Limula and CSEM collaborate to make cellular therapies more accessible

Monday 13 February 2023
Leading private healthcare facility Hôpital de la Tour has entered into a CHF 750 million agreement to create a major health campus project to promote innovation and medical research in the canton of Geneva.

Hôpital de La Tour will invest CHF 750 million to create a health campus in Geneva

Monday 13 February 2023
The MAINLINE project is an international recognition for a CHUV and Alithea Genomics research project that aims to make immunotherapy treatments more targeted.

Alithea Genomics and CHUV to help make immunotherapy treatments more targeted

Monday 30 January 2023
Bionomous has developed the EggSorter, which is designed to handle zebrafish eggs and similar entities, and which is now already being commercialized in Europe, US and China.

Bionomous secures USD 2.7 million to automate life science research

Tuesday 24 January 2023
The CMV focuses on the integration of virtual reality and related new technologies into clinical research and patient care.

The Geneva University Hospitals launch the Center for Virtual Medicine

Tuesday 24 January 2023
Through the creation of DNA nanosensors, the research conducted at the University of Fribourg could lead to the development of faster, safer, simpler, and more affordable diagnostic tests for cancer.

The University of Fribourg unveils bioinspired nanosensors for early detection of cancer

Wednesday 18 January 2023

This website uses cookies to improve user experience. More information